Black Friday 25% off both GutID tests, through Cyber Monday. No code needed. 25% off both tests, through Cyber Monday Shop the sale
Free shipping both waysHSA/FSA eligible in the USResults 3–4 weeks after lab receipt

Biomesight vs. Viome vs. GI-MAP: How Three Gut Tests Compare in the UK

Biomesight, Viome and GI-MAP® all start with a stool sample, but they measure different things. Biomesight sequences part of the bacterial 16S rRNA gene to show which bacteria are present, Viome sequences microbial RNA to score activity, and GI-MAP is a practitioner-ordered qPCR panel that looks for named pathogens, parasites and fungi alongside gut-function markers. In the UK, Biomesight posts kits here with free tracked returns, GI-MAP is bought privately through a practitioner rather than on the NHS, and Viome's current pages do not list a UK price.

If you want to see your entire gut bacterial ecosystem, GutID is built for it. Titan-1™ long-read sequencing reads about 2,500 continuous bases of each bacterium's ribosomal DNA, 5–10 times more than a short-read 16S test, to identify bacteria to species across the whole community, and it is backed by more than 30 peer-reviewed publications.

This comparison is for people in the UK weighing up these tests, including anyone who searched for a Biomesight review or for Biomesight vs Ombre. It covers what each test measures, how you get it here, what it costs at time of writing (October 2026) and when each one fits. For NHS options and a wider look at UK costs, see our UK gut microbiome test guide.

Biomesight vs. Viome vs. GI-MAP at a glance

Attribute Biomesight Viome Gut Intelligence™ Test GI-MAP® GutID
Who orders it You, online You, online A healthcare practitioner You, online
Method 16S rRNA sequencing (V4 region) RNA (metatranscriptomic) sequencing Quantitative PCR (qPCR) targeting specific organisms' DNA Titan-1™ long-read sequencing: one continuous read of about 2,500 bases across the full 16S gene, the ITS and the start of 23S
What it measures Bacteria from phylum to species; Gut Wellness Score; 47 key bacteria and 18 functional markers Microbial activity across 400+ pathways, reported as 25+ gut health scores Bacterial, parasitic and viral pathogens, H. pylori, commensal bacteria, fungi and intestinal health markers The entire bacterial ecosystem: species-level identification and relative abundance, diversity and balance, including bacteria with no species name yet
Sample Stool swab into a tube of preservative At-home stool sample Single stool sample in a vial At-home stool sample
Analysed at A US CLIA laboratory Viome's CLIA-certified laboratory DSL in Alpharetta, Georgia, US A CLIA laboratory in the US
Results 2–3 weeks after receipt for UK samples Not stated on the product page About 3 weeks via Nordic Laboratories About 4–5 weeks after the lab receives the sample
UK price (at time of writing) £159 single test (Biomesight's sterling shop) No sterling price listed ($279 on viome.com) £355–£395 at two UK clinics, plus any consultation fee £279 Core Gut Insights; £409 Complete Microbiome Assessment
UK access Free kit delivery and free tracked returns UK delivery not confirmed on current pages Private only, through a practitioner Free shipping both ways
Best suited to Bacterial snapshots you can repeat and track Activity-based scores and food lists in an app Practitioner-led checks for specific organisms and gut-function markers Seeing your entire bacterial ecosystem at species level and how it shifts over time

How each test works

Biomesight: a 16S bacterial profile

Biomesight is run by a company registered in England, and its kit is a stool swab placed in a tube of preservative. Its sample report gives the method as 16S rRNA sequencing of the V4 region, with results from phylum down to species. The report includes a Gut Wellness Score, diversity, 47 key bacteria and 18 functional markers set against reference ranges, then ranked food, prebiotic, probiotic and supplement suggestions. You can download your raw data as FASTQ and CSV files and retest to track scores over time. Biomesight notes that its functional ratings are estimated from the bacteria that produce them rather than measured directly, and says its service is not intended to diagnose any disease.

Viome: RNA-based activity scores

Viome's Gut Intelligence™ Test uses metatranscriptomic sequencing, which reads RNA rather than DNA. Viome says this shows not only which microbes are present but how they are living, and it analyses activity across more than 400 biological pathways. Results arrive in an app as more than 25 gut health scores and more than 370 personalised food recommendations. Viome says collection takes about five minutes and that samples are analysed in its CLIA-certified laboratory. For a closer look at RNA versus DNA approaches, read our GutID vs. Viome comparison.

GI-MAP: a practitioner-ordered qPCR panel

Diagnostic Solutions Laboratory (DSL) describes GI-MAP as a comprehensive stool test that uses quantitative PCR to detect parasites, bacteria, H. pylori, fungi and more by targeting the DNA of the organisms tested, and calls it a diagnostic tool. Its sample report covers bacterial, parasitic and viral pathogens, H. pylori virulence factors, commensal and opportunistic bacteria, fungi and yeast, and intestinal health markers such as elastase-1, calprotectin, secretory IgA and a faecal immunochemical test for occult blood. A healthcare practitioner has to order it. Our guide to what a GI-MAP tests for walks through the markers.

Getting each test in the UK

Biomesight ships kits free to the UK with a postage-paid return mailer, and returns from the UK are tracked. UK samples are posted to a UK address and then batched to its US laboratory, which is why Biomesight quotes 2–3 weeks for UK results against 1–2 weeks in the US. At time of writing, its sterling web shop listed a single test at £159. Biomesight shows prices by country, so confirm the figure at checkout.

GI-MAP is not available on the NHS, so you pay privately through a practitioner. Two UK clinics we checked say they order it through Nordic Laboratories, a Copenhagen-based testing company whose GI-MAP listing names DSL as the laboratory and gives a turnaround of 21 days, give or take four. Nordic's collection instructions ask you to collect on a Sunday or Monday, keep the sample refrigerated, and post it with a frozen gel pack within a day. Those two clinics listed the test at £355 and £395 at time of writing, and one charges £300 for the results consultation.

Viome advertises free US shipping on its product pages, and its distributor page describes prepaid sample returns from the US and Canada. We could not find a current Viome page confirming UK delivery or a price in pounds, so check at checkout before ordering.

What about Ombre?

If you searched for Biomesight vs Ombre, note that Ombre's help centre says its test kits are only available for purchase within the United States, so it cannot be ordered to a UK address at time of writing. Like Biomesight, Ombre bases its test on 16S rRNA sequencing.

Key differences

  • What is measured. Biomesight reads bacterial DNA, Viome reads microbial RNA, and GI-MAP measures a defined list of DNA targets plus intestinal health markers. Our explainer on 16S, shotgun and long-read sequencing covers how sequencing methods differ.
  • Open profile or set targets. Sequencing tests report whichever bacteria they find in the sample; a qPCR panel quantifies the organisms it is designed to look for.
  • Who orders. You can buy Biomesight or Viome yourself. GI-MAP needs a practitioner, and Nordic releases results to that practitioner.
  • Intended use. Biomesight and Viome say their services are not intended to diagnose disease; DSL calls GI-MAP a diagnostic tool.

When Biomesight is the right choice

Biomesight fits if you want a bacterial profile you can order yourself, send back within the UK without customs paperwork, and repeat to see whether your scores shift. It also suits people who like to explore their own data, since the raw sequencing files are included.

When Viome is the right choice

Viome fits if you are specifically interested in RNA-based measures of what gut microbes are doing, and you want your results as scores and food recommendations in an app.

When GI-MAP is the right choice

GI-MAP fits when a practitioner wants to check for specific pathogens, parasites, H. pylori or markers such as calprotectin and elastase, and will go through the results with you. Anyone with a suspected acute infection or red-flag symptoms, such as blood in the stool, unexplained weight loss, fever, or severe or persistent diarrhoea, should see their GP or another clinician for diagnostic testing.

When GutID is the better choice

  • You want the whole picture. GutID sees the entire bacterial ecosystem: which species are present, how much of the community each holds, and how diverse and balanced it is.
  • You want to tell close relatives apart. Titan-1's roughly 2,500-base read gives GutID far more sequence than a short-read 16S test to separate similar species.
  • You want what nobody thought to test for. GutID identifies organisms a fixed panel can't, including bacteria with no species name yet.
  • You want more than the gut. The Complete Microbiome Assessment adds the gut-brain, gut-immune, gut-metabolism and gut-heart axes.

Why GutID sees more

First, the read. A short-read 16S test reads one variable stretch of a single gene: roughly 250 bases for the V4 region named in Biomesight's report. Titan-1 reads a patented fragment of about 2,500 bases, spanning the full 16S gene, the internal transcribed spacer (ITS) and the start of the 23S gene, in one continuous read, re-reading each molecule to build a consensus. Depending on the region a short-read test uses, that is 5–10 times more of each bacterium's ribosomal DNA.

GutID's own classifier then identifies organisms from the whole read, not by matching short markers to a fixed database, turning strain-level data into species-level identification with relative abundance, even for bacteria with no species name. A qPCR panel such as GI-MAP measures a chosen list of organisms, so reading the whole community gives a more complete picture of the bacterial ecosystem than a targeted panel.

The method is peer-reviewed: more than 30 publications use the long-read approach behind Titan-1. A 2022 Microbial Genomics study comparing short-read 16S with long-read 16S–ITS–23S profiling on clinical-trial samples found that only the long-read approach provided strain-level community resolution and insight into novel taxa. See the science behind Titan-1, the research cited in every report and a sample report. GutID Pro, which puts the ecosystem and 65 targeted markers in one kit, is ordered by approved US clinicians and is not available in the UK.

Frequently asked questions

What is Biomesight and how does it work?

Biomesight is an at-home gut bacteria test from a company registered in England. You swab a stool sample into preservative and post it back free from the UK, and a US laboratory sequences the bacterial 16S rRNA gene. Results appear online, usually 2–3 weeks after a UK sample arrives.

Can I get a GI-MAP test on the NHS?

No. GI-MAP is not an NHS test, so it is ordered and paid for privately through a practitioner. If you have symptoms, start with your GP.

Does Viome ship to the UK?

We could not confirm it at time of writing: Viome's current pages describe US shipping and returns from the US and Canada, with no price in pounds. Check at checkout before you order.

Biomesight vs Ombre: which can I buy in the UK?

Biomesight delivers to UK addresses with free tracked returns. Ombre says its kits are only available for purchase within the United States, so it cannot be sent to a UK address at time of writing.

Which gut bacteria test should I choose in the UK?

Start with your question. To see your entire bacterial ecosystem at species level and track it over time, choose GutID. For a 16S bacterial snapshot with downloadable raw data, Biomesight fits; for RNA-based activity scores, consider Viome if it delivers to you. For checks on specific pathogens or gut-function markers, ask a practitioner about GI-MAP.

Is GutID better than Biomesight, Viome or GI-MAP?

For seeing your entire bacterial ecosystem, yes. GutID reads 5–10 times more of each bacterium's ribosomal DNA than a short-read 16S test such as Biomesight's and quantifies bacteria even without a species name. Against a targeted panel such as GI-MAP, it gives a more complete picture of the bacterial ecosystem and identifies organisms a fixed panel can't. Viome scores microbial activity from RNA; GutID shows which bacteria are present, to species, and in what proportions. More than 30 peer-reviewed publications back its long-read approach.

Sources

  1. Gut microbiome test — Biomesight (accessed October 30, 2026)
  2. How it works — Biomesight (accessed October 30, 2026)
  3. Shipping — Biomesight (accessed October 30, 2026)
  4. Return address and customs instructions — Biomesight (accessed October 30, 2026)
  5. Sample gut microbiome report — Biomesight (accessed October 30, 2026)
  6. FAQ — Biomesight (accessed October 30, 2026)
  7. Gut Microbiome Test (snapshot) — Biomesight shop (accessed October 30, 2026)
  8. Gut Intelligence™ Test — Viome (accessed October 30, 2026)
  9. Our science — Viome (accessed October 30, 2026)
  10. Distributors — Viome (accessed October 30, 2026)
  11. Terms of service — Viome (accessed October 30, 2026)
  12. GI-MAP – GI Microbial Assay Plus — Diagnostic Solutions Laboratory (accessed October 30, 2026)
  13. GI-MAP sample report — Diagnostic Solutions Laboratory (accessed October 30, 2026)
  14. GI-MAP stool test — Nordic Laboratories (accessed October 30, 2026)
  15. GI-MAP collection instructions — Nordic Laboratories (accessed October 30, 2026)
  16. GI-MAP test UK — IBS Clinics (accessed October 30, 2026)
  17. GI-MAP test UK — Phil Richards Nutrition Lab (accessed October 30, 2026)
  18. Do you ship internationally? — Ombre (accessed October 30, 2026)
  19. Gut Microbiome Health Test — Ombre (accessed October 30, 2026)
  20. Finding the right fit: evaluation of short-read and long-read sequencing approaches to maximize the utility of clinical microbiome data (Gehrig et al., 2022) — Microbial Genomics (accessed October 30, 2026)

GutID provides wellness and educational insights and is not a diagnostic test. GI-MAP®, Gut Intelligence™, Viome, Biomesight and Ombre are trademarks of their respective owners. GutID is not affiliated with Diagnostic Solutions Laboratory, Viome Life Sciences, Biomesight, Nordic Laboratories or Ombre.

This article is for education and is not medical advice. GutID provides wellness and educational insights and is not a diagnostic test.

Read two real sample reports.

Two full reports from one de-identified person, before and after an intervention, sent to your inbox.